19-51692513-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The NM_001316994.2(SPACA6):​c.92-1965G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00383 in 434,878 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.0091 ( 15 hom., cov: 32)
Exomes 𝑓: 0.0010 ( 3 hom. )

Consequence

SPACA6
NM_001316994.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.57

Publications

2 publications found
Variant links:
Genes affected
SPACA6 (HGNC:27113): (sperm acrosome associated 6) Predicted to be involved in fusion of sperm to egg plasma membrane involved in single fertilization. Predicted to be located in acrosomal vesicle. [provided by Alliance of Genome Resources, Apr 2022]
SPACA6-AS1 (HGNC:49383): (SPACA6 antisense RNA 1)
MIR99B (HGNC:31651): (microRNA 99b) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00911 (1385/152064) while in subpopulation AFR AF = 0.0312 (1295/41484). AF 95% confidence interval is 0.0298. There are 15 homozygotes in GnomAd4. There are 637 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 15 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPACA6NM_001316994.2 linkc.92-1965G>A intron_variant Intron 1 of 8 NP_001303923.1
SPACA6-AS1NR_108100.1 linkn.823+121C>T intron_variant Intron 1 of 1
SPACA6XM_017026300.3 linkc.-41-1965G>A intron_variant Intron 1 of 8 XP_016881789.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPACA6ENST00000710615.1 linkc.-41-1965G>A intron_variant Intron 1 of 8 ENSP00000518379.1
SPACA6ENST00000646845.1 linkc.368-1965G>A intron_variant Intron 1 of 1 ENSP00000496692.1 A0A2R8Y8C0
SPACA6-AS1ENST00000602324.1 linkn.823+121C>T intron_variant Intron 1 of 1 2
MIR99BENST00000384819.1 linkn.-99G>A upstream_gene_variant 6

Frequencies

GnomAD3 genomes
AF:
0.00904
AC:
1374
AN:
151946
Hom.:
13
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0310
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00380
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000265
Gnomad OTH
AF:
0.00671
GnomAD4 exome
AF:
0.000997
AC:
282
AN:
282814
Hom.:
3
AF XY:
0.000837
AC XY:
136
AN XY:
162536
show subpopulations
African (AFR)
AF:
0.0305
AC:
189
AN:
6200
American (AMR)
AF:
0.00260
AC:
39
AN:
15016
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
8360
East Asian (EAS)
AF:
0.00
AC:
0
AN:
9764
South Asian (SAS)
AF:
0.0000742
AC:
4
AN:
53938
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
24252
Middle Eastern (MID)
AF:
0.00309
AC:
3
AN:
972
European-Non Finnish (NFE)
AF:
0.000125
AC:
19
AN:
151808
Other (OTH)
AF:
0.00224
AC:
28
AN:
12504
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.523
Heterozygous variant carriers
0
14
29
43
58
72
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00911
AC:
1385
AN:
152064
Hom.:
15
Cov.:
32
AF XY:
0.00857
AC XY:
637
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.0312
AC:
1295
AN:
41484
American (AMR)
AF:
0.00373
AC:
57
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5160
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10592
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000265
AC:
18
AN:
67938
Other (OTH)
AF:
0.00664
AC:
14
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
71
142
212
283
354
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000374
Hom.:
0
Bravo
AF:
0.0107
Asia WGS
AF:
0.00404
AC:
14
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
4.9
DANN
Benign
0.43
PhyloP100
1.6
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8112073; hg19: chr19-52195766; API